CeriBell (NasdaqGS:CBLL) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsBrian Johnston - Investor Relations ContactJane Chao - Co-Founder and CEOJeffrey Cohen - Managing Director and Director of Equity ResearchScott Blumberg - CFOTravis Steed - Managing Director of Equity ResearchConference Call ParticipantsBill Plovanic - Managing Director of Equity Research and Medical Technology AnalystBrandon Vazquez - Equity Research AnalystMarie Thibault - Managing Director and Medical Technol ...

CeriBell (NasdaqGS:CBLL) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Speaker7Hello, and welcome to the CeriBell Q4 2025 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number 1 on your telephone keypad. If you would like to withdraw your question, press star 1 again. Thank you. I will now turn the call ove ...

来源：环球市场播报 美敦力旗下 MiniMed 集团周二表示，其美国首次公开发行（IPO）的目标估值最高可达78.6 亿美元，标 志着这家医疗设备制造商分拆糖尿病业务的计划迈出重要一步。 这家总部位于加州北岭的子公司是糖尿病护理领域的龙头企业，主要生产胰岛素泵、血糖监测系统及传 感器等产品。此次 IPO 计划发行2800 万股，发行价区间为每股25 至 28 美元，拟最高募资7.84 亿美 元。 米尔鲍尔指出："尽管公司营收增长强劲，但成为独立实体的代价是失去美敦力的财务安全垫。 MiniMed 已连续三年录得净亏损，这意味着投资者将要求其给出清晰的盈利路径。" 美敦力预计在 IPO 完成6 个月后，对 MiniMed 进行后续完全分拆。 高盛、美银证券、花旗集团及摩根士丹利担任此次 IPO 的联席簿记管理人。MiniMed 拟在纳斯达克上 市，股票代码为MMED。 IPOX 研究助理卢卡斯・米尔鲍尔表示："MiniMed 拥有超过 40 年的胰岛素泵生产历史，它是以成熟企 业而非初创公司的身份进入市场的。此次分拆将让公司能够面向希望单纯布局糖尿病科技领域的投资 者。" 美敦力去年曾宣布，计划通过 IPO 及 ...

AxoGen (AXGN) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.08 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -50.00%. A quarter ago, it was expected that this regenerative medicine company would post earnings of $0.09 per share when it actually produced earnings of $0.12, delivering a surprise of +33.33%.Over the last four quarter ...

Establishment Labs (NasdaqCM:ESTA) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Speaker7Thank you, operator, and thank you everyone for joining us. With me today is Peter Caldini, as well as other SEC filings, which are available on our website at establishmentlabs.com. I'd also like to remind you that our comments may include certain non-GAAP financial measures with respect to our performance, including but not limited to sales results, which can be stated on a constant currency basis, or EBITDA, wh ...

香港联交所最新资料显示，2月20日，The Goldman Sachs Group,Inc.增持爱康医疗(01789)142万股，每股 作价6.26港元，总金额为888.92万港元。增持后最新持股数目约为5760.54万股，最新持股比例为 5.13%。 ...

摘要：丹纳赫2026年2月18日宣布以约99亿美元收购Masimo，溢价超40%，预计2026年下半年完成。 Masimo将作为其诊断业务部门内独立公司运营，增强丹纳赫在数字健康和患者监测领域实力。 摘要：丹纳赫2026年2月18日宣布以约99亿美元收购Masimo，溢价超40%，预计2026年下半年完成。 Masimo将作为其诊断业务部门内独立公司运营，增强丹纳赫在数字健康和患者监测领域实力。 ...

来源：新浪证券-红岸工作室 2月24日，港通医疗涨1.64%，成交额5584.39万元，换手率3.29%，总市值26.07亿元。 异动分析 脑机接口+智能医疗+医疗器械概念+专精特新+西部大开发 1、2025年7月3日互动易：脑机接口手术通常在高级别洁净手术室进行，且需要配置有稳定、可靠的各 种医用气体（包括：医用氧气、医用真空、医疗空气、医用氧化亚氮及医用二氧化碳等），公司主营业 务为医用气体装备及系统、医用洁净装备及系统的研发、设计、制造、集成及运维服务。在脑机接口手 术全流程中，公司的医用气体装备及系统可保障各种医用气体的持续供应，医用洁净装备及系统可保障 手术室及相关区域达到手术要求的洁净标准，降低术后感染风险，符合手术安全标准。公司的现有产品 在脑机接口手术的基础环境支持中具有较明确的应用价值。 2、2023年半年报：公司开发了港通云监测平台，并取得相关软件著作权，运用先进的物联网技术、楼 宇自动化技术、在线云监测技术等，为医院提供一套先进的医疗设备实时监控方案。医疗设备在线集中 监控系统包括本地集中监控中心和在线监测平台两部分，两者相对独立，分别实现对医用设备的本地监 控和物联网远程监测。 3、四 ...

Report Summary 1. Report's Industry Investment Rating No relevant information provided. 2. Core Viewpoints - Global financial markets are affected by multiple factors including geopolitical tensions, tariff policies, and corporate earnings, leading to significant fluctuations in various asset classes. For example, the US stock market declined due to Trump's tariff plan and EU's suspension of the trade - agreement approval, while the precious metals market rose due to increased risk - aversion [5][6]. - The energy market is influenced by the Iran - US nuclear negotiation, with expectations of increased Iranian oil supply putting downward pressure on oil prices [7]. 3. Summary by Directory Overnight Night - Market Trends - **Stock Markets**: US major indices (Dow, S&P 500, Nasdaq) fell, with IBM and American Express leading the decline. European indices (DAX, CAC40, FTSE 100) also closed lower. The reasons include Trump's tariff plan and EU's suspension of trade - agreement approval [5]. - **Precious Metals**: COMEX gold and silver futures rose due to increased risk - aversion from geopolitical tensions, tariff policy changes, and other factors [6]. - **Energy**: US crude oil and Brent oil futures fell as the Iran - US nuclear negotiation showed signs of progress, increasing the expectation of more Iranian oil supply [7]. - **Base Metals**: Most London base metals declined, except for LME tin which rose [7]. Important News Macro News - Shanghai Export Container Settlement Freight Index for European routes dropped 2.1%. The US will stop collecting certain illegal tariffs. There is still a risk of US military strikes against Iran. India postponed a trade delegation plan. China is assessing the impact of US tariff rulings and urges the US to cancel unilateral tariffs. The EU suspended the approval of a trade agreement with the US. The Trump administration is considering new "national security tariffs" [9][11]. Energy Futures - Saudi Aramco sold condensate oil. Methanol supply in Southeast Asia is restricted due to planned maintenance. Goldman Sachs and Morgan Stanley have different forecasts for oil prices, with Goldman Sachs raising price forecasts for Q4 2026 and 2027, and Morgan Stanley expecting a short - term increase followed by a decline [14][16][18]. Metal Futures - The US energy storage market is expected to grow 21%. Lebanon may sell part of its gold reserves. UBS is positive on gold, with a target price of $6200/ounce [20][21]. Black - Series Futures - China's iron ore arrivals decreased, but global iron ore shipments increased. Vietnam plans to build a large - scale steel plant. The blast furnace capacity utilization rate of Chinese pig - iron enterprises decreased, and inventory increased [23][25]. Agricultural Products Futures - Malaysian palm oil production and exports decreased in February. Argentina's soybean moisture conditions improved, and the production forecast remains unchanged [27][28]. Financial Markets Financial - 143 companies have submitted IPO applications in the Hong Kong stock market in 2026. Deloitte predicts a better performance in the Hong Kong IPO market this year [30]. Industry - Payment transactions on Chinese New Year's Eve increased. The real - estate market may show more stabilization signals. China's AI governance system is maturing [31]. Overseas - The US may adjust tariff application methods and continue steel - aluminum tariffs. The Fed has about 75 basis - points to reach the neutral rate. India plans to invest $200 billion in AI. The Australian central bank may tighten policy. UK unemployment reached a new high [32][34][35]. International Stock Markets - US and European stock markets rose, while the Japanese market fell. High - end companies made significant stock - position adjustments. The UK may adjust accounting rules to attract Chinese companies. Australia simplifies corporate governance rules. Some companies announced major transactions or reported good earnings [36][38][41]. Commodities - Precious metals, oil, and most base metals futures fell due to factors such as progress in the Iran - US nuclear negotiation and reduced risk - aversion [43]. Bonds - US Treasury yields had mixed changes. Japanese bonds rose, and the 2029 fiscal - year bond issuance may increase [45]. Foreign Exchange - The US dollar index rose slightly, and most non - US currencies fell [46]. Upcoming Economic Data and Events - **Economic Data**: Include Japan's trade balance, UK's inflation and housing - price index, US's new - home construction, and other data [48]. - **Events**: New Zealand's central - bank rate decision, European Central Bank officials' speeches, and the Fed's release of meeting minutes [50]. - **Market Closures**: Chinese, South Korean, and Vietnamese stock markets are closed due to the Spring Festival [52].

Core Viewpoint - The development of an implantable microcrystalline hydrogel sensor using near-infrared 3D printing technology represents a significant technological breakthrough in non-invasive in-situ construction for physiological signal monitoring [1][3]. Group 1: Technology Innovation - The research team has created a flexible hydrogel biosensor that can be formed directly in the body, addressing the limitations of traditional surgical implantation methods [3]. - The innovative technology utilizes near-infrared 3D printing to induce in-body photopolymerization through a core-shell upconversion nanoparticle and indocyanine green sensitization mechanism [3][4]. Group 2: Performance and Applications - In animal experiments with mice, the sensor accurately captured muscle movement states and converted them into electrical signals without any invasive procedures, demonstrating excellent monitoring capabilities [3]. - The multifunctional microcrystalline hydrogel material used in the sensor offers good flexibility and biocompatibility, paving the way for non-invasive solutions in customized manufacturing of implantable sensors [4]. - This technology has the potential for widespread application in clinical scenarios such as neuromuscular monitoring and chronic disease management, promoting the development of medical monitoring devices towards non-invasiveness, precision, and personalization [4].